Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EURAMOS-1: Treatment Strategies for Resectable Osteosarcoma
NCT00134030Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Nov 2005
- Primary completion
- Jan 2015
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons, Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of peginterferon alfa-2b, ifosfamide, etoposide in osteosarcoma (OS), sponsored by Children's Oncology Group. Started Nov 2005; status: completed.
02
Drugs
peginterferon alfa-2bifosfamideetoposide
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT00134030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134030.